Insulet
PODD
#1053
Rank
ยฃ14.33 B
Marketcap
ยฃ204.30
Share price
-1.47%
Change (1 day)
23.50%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Revenue for Insulet (PODD)

Revenue in 2024 (TTM): ยฃ1.54 Billion

According to Insulet's latest financial reports the company's current revenue (TTM ) is ยฃ1.56 Billion. In 2023 the company made a revenue of ยฃ1.33 Billion an increase over the revenue in the year 2022 that were of ยฃ1.07 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Insulet from 2006 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ1.54 B15.79%
2023 ยฃ1.33 B23.46%
2022 ยฃ1.07 B32.54%
2021 ยฃ0.81 B22.69%
2020 ยฃ0.66 B17.86%
2019 ยฃ0.56 B26.74%
2018 ยฃ0.44 B29.44%
2017 ยฃ0.34 B15.37%
2016 ยฃ0.29 B57.29%
2015 ยฃ0.18 B1.96%
2014 ยฃ0.18 B23.8%
2013 ยฃ0.14 B14.54%
2012 ยฃ0.13 B33.5%
2011 ยฃ97.95 M55.95%
2010 ยฃ62.81 M53.93%
2009 ยฃ40.8 M65.85%
2008 ยฃ24.6 M265.52%
2007 ยฃ6.73 M237.28%
2006 ยฃ1.99 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ1.84 B 17.95%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.64 B-58.76%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ3.11 B 99.30%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ69.04 B 4,320.38%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ32.45 B 1,977.57%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ25.97 B 1,563.19%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
ยฃ32.17 B 1,959.75%๐Ÿ‡บ๐Ÿ‡ธ USA